Candida parapsilosis, an emerging fungal pathogen

Clinical Microbiology Reviews

Volumn 21, Issue 4, 2008, Pages 606-625

  Trofa, David ^a   Gácser, Attila ^b   Nosanchuk, Joshua D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; ASPARTIC PROTEINASE; BORIC ACID; BUCONAZOLE; CASPOFUNGIN; CLOTRIMAZOLE; CORTICOSTEROID; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; NELFINAVIR; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RITONAVIR; SAQUINAVIR; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VORICONAZOLE;

BIOFILM; CANDIDA PARAPSILOSIS; CANDIDEMIA; CANDIDIASIS; CLINICAL FEATURE; EAR INFECTION; EYE INFECTION; FUNGAL ENDOCARDITIS; FUNGAL MENINGITIS; FUNGAL VIRULENCE; FUNGEMIA; FUNGUS ISOLATION; HUMAN; INCIDENCE; INFECTION RISK; INFECTIOUS ARTHRITIS; MONOTHERAPY; MORTALITY; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; PERITONITIS; PREVALENCE; REVIEW; RISK FACTOR; URINARY TRACT INFECTION; VULVOVAGINITIS;

CANDIDA; CANDIDIASIS; CROSS INFECTION; HUMANS; PREVALENCE; VIRULENCE FACTORS;

CANDIDA PARAPSILOSIS;

EID: 54249158265     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00013-08     Document Type: Review

References (301)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333-2338.
2. Abu-Elteen, K. H., A. M. Abdul Malek, and N. A. Abdul Wahid. 1997. Prevalence and susceptibility of vaginal yeast isolates in Jordan. Mycoses 40:179-185.
3. Adler-Shohet, F., H. Waskin, and J. M. Lieberman. 2001. Amphotericin B lipid complex for neonatal invasive candidiasis. Arch. Dis. Child Fetal Neonatal ed. 84:F131-F133.
4. Agatensi, L., F. Franchi, F. Mondello, R. L. Bevilacqua, T. Ceddia, F. De Bernardis, and A. Cassone. 1991. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J. Clin. Pathol. 44:826-830.
5. Almirante, B., D. Rodriguez, M. Cuenca-Estrella, M. Almela, F. Sanchez, J. Ayats, C. Alonso-Tarres, J. L. Rodriguez-Tudela, and A. Pahissa. 2006. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 44:1681-1685.
6. Alonso-Valle, H., O. Acha, J. D. Garcia-Palomo, C. Farinas-Alvarez, C. Fernandez-Mazarrasa, and M. C. Farinas. 2003. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur. J. Clin. Microbiol. Infect. Dis. 22:254-257.
7. Al-Tawfiq, J. A. 2007. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004. Int. J. Infect. Dis. 11:239-244.
8. Alvarez-Lerma, F., J. Nolla-Salas, C. Leon, M. Palomar, R. Jorda, N. Carrasco, and F. Bobillo. 2003. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 29:1069-1076.
9. Amici, G., S. Grandesso, A. Mottola, G. Virga, G. Calconi, and C. Bocci. 1994. Fungal peritonitis in peritoneal dialysis: critical review of six cases. Adv. Perit. Dial. 10:169-173.
10. Arias, A., M. P. Arevalo, A. Andreu, C. Rodriguez, and A. Sierra. 1994. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Mycoses 37:285-289.
11. Asencio, M. A., E. Garduno, C. Perez-Giraldo, M. T. Blanco, C. Hurtado, and A. C. Gomez-Garcia. 2005. Exposure to therapeutic concentrations of ritonavir, but not saquinavir, reduces secreted aspartyl proteinase of Candida parapsilosis. Chemotherapy 51:252-255.
12. Ashford, B. 1928. Certain conditions of the gastrointestinal tract in Puerto Rico and their relation to tropical sprue. Am. J. Trop. Med. Hyg. 8:507-538.
13. Baddour, L. M. 1995. Long-term suppressive therapy for Candida parapsilosis-induced prosthetic valve endocarditis. Mayo Clin. Proc. 70:773-775.
14. Baillie, G. S., and L. J. Douglas. 1999. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48:671-679.
15. Baley, J. E., C. Meyers, R. M. Kliegman, M. R. Jacobs, and J. L. Blumer. 1990. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J. Pediatr. 116:791-797.
16. Baran, J., Jr., B. Muckatira, and R. Khatib. 2001. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand. J. Infect. Dis. 33:137-139.
17. Barchiesi, F., E. Spreghini, S. Tomassetti, A. Della Vittoria, D. Arzeni, E. Manso, and G. Scalise. 2006. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis. Antimicrob. Agents Chemother. 50:2719-2727.
18. Barchiesi, F., E. Spreghini, S. Tomassetti, D. Giannini, and G. Scalise. 2007. Caspofungin in combination with amphotericin B against Candida parapsilosis. Antimicrob. Agents Chemother. 51:941-945.
19. Barnes, S. D., C. H. Dohlman, and M. L. Durand. 2007. Fungal colonization and infection in Boston keratoprosthesis. Cornea 26:9-15.
20. Barrett-Bee, K., Y. Hayes, R. G. Wilson, and J. F. Ryley. 1985. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J. Gen. Microbiol. 131:1217-1221.
21. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.
22. Bassetti, M., E. Righi, A. Costa, R. Fasce, M. P. Molinari, R. Rosso, F. B. Pallavicini, and C. Viscoli. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6:21.
23. Bauters, T. G., M. A. Dhont, M. I. Temmerman, and H. J. Nelis. 2002. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am. J. Obstet. Gynecol. 187:569-574.
24. Bayer, A. S., M. J. Blumenkrantz, J. Z. Montgomerie, J. E. Galpin, J. W. Coburn, and L. B. Guze. 1976. Candida peritonitis. Report of 22 cases and review of the English literature. Am. J. Med. 61:832-840.
25. Bendel, C. M. 2003. Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin. Perinatol. 27:357-364.
26. Benjamin, D. K., E. DeLong, C. M. Cotten, H. P. Garges, W. J. Steinbach, and R. H. Clark. 2004. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J. Perinatol. 24:175-180.
27. Benjamin, D. K., Jr., K. Ross, R. E. McKinney, Jr., D. K. Benjamin, R. Auten, and R. G. Fisher. 2000. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106:712-718.
28. Bonassoli, L. A., M. Bertoli, and T. I. Svidzinski. 2005. High frequency of Candida parapsilosis on the hands of healthy hosts. J. Hosp. Infect. 59:159-162.
29. Borg-von Zepelin, M., L. Kunz, R. Ruchel, U. Reichard, M. Weig, and U. Gross. 2007. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J. Antimicrob. Chemother. 60:424-428.
30. Bosch Mestres, J., M. Esque Ruiz, and X. Carbonell Estrany. 1990. Severe infection caused by Candida parapsilosis in an infant. An. Esp. Pediatr. 32:70-72.
31. Bourcier, T., O. Touzeau, F. Thomas, C. Chaumeil, M. Baudrimont, V. Borderie, and L. Laroche. 2003. Candida parapsilosis keratitis. Cornea 22:51-55.
32. Branchini, M. L., M. A. Pfaller, J. Rhine-Chalberg, T. Frempong, and H. D. Isenberg. 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J. Clin. Microbiol. 32:452-456.
33. Brielmaier, B. D., E. Casabar, C. M. Kurtzeborn, P. S. McKinnon, and D. J. Ritchie. 2008. Early clinical experience with anidulafungin at a large tertiary care medical center. Pharmacotherapy 28:64-73.
34. Brito, L. R., T. Guimaraes, M. Nucci, R. C. Rosas, L. Paula Almeida, D. A. Da Matta, and A. L. Colombo. 2006. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med. Mycol. 44:261-266.
35. Brockerhoff, H. 1974. Model of interaction of polar lipids, cholesterol, and proteins in biological membranes. Lipids 9:645-650.
36. Brooks, D. H., and F. Pupparo. 1998. Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J. Arthroplasty 13:707-712.
37. Brunel, L., V. Neugnot, L. Landucci, H. Boze, G. Moulin, F. Bigey, and E. Dubreucq. 2004. High-level expression of Candida parapsilosis lipase/acyltransferase in Pichia pastoris. J. Biotechnol. 111:41-50.
38. Cancelas, J. A., J. Lopez, E. Cabezudo, E. Navas, J. Garcia Larana, M. Jimenez Mena, P. Diz, J. Perez de Oteyza, L. Villalon, A. Sanchez-Sousa, et al. 1994. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia. Bone Marrow Transplant. 13:333-334.
39. Cassone, A., F. De Bernardis, E. Pontieri, G. Carruba, C. Girmenia, P. Martino, M. Fernandez-Rodriguez, G. Quindos, and J. Ponton. 1995. Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J. Infect. Dis. 171:967-975.
40. Castillo Caparros, A., and A. M. Montijano Cabrera. 2002. Candida parapsilosis endocarditis after prolonged antibiotic therapy. Rev. Esp. Anestesiol. Reanim. 49:209-212.
41. Chakrabarti, A. 2007. Epidemiology of central nervous system mycoses. Neurol. India 55:191-197.
42. Chamilos, G., R. E. Lewis, N. Albert, and D. P. Kontoyiannis. 2007. Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob. Agents Chemother. 51:2257-2259.
43. Chen, C. M., M. W. Ho, W. L. Yu, and J. H. Wang. 2004. Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. J. Microbiol. Immunol. Infect. 37:115-120.
44. Chen, K. H., C. T. Chang, C. C. Yu, J. Y. Huang, C. W. Yang, and C. C. Hung. 2006. Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients. Renal Fail. 28:241-246.
45. Chesney, P. J., R. A. Justman, and W. M. Bogdanowicz. 1978. Candida meningitis in newborn infants: a review and report of combined amphotericin B-flucytosine therapy. Johns Hopkins Med. J. 142:155-160.
46. Cheung, C., Y. Guo, P. Gialanella, and M. Feldmesser. 2006. Development of candidemia on caspofungin therapy: a case report. Infection 34:345-348.
47. Clark, T. A., S. A. Slavinski, J. Morgan, T. Lott, B. A. Arthington-Skaggs, M. E. Brandt, R. M. Webb, M. Currier, R. H. Flowers, S. K. Fridkin, and R. A. Hajjeh. 2004. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J. Clin. Microbiol. 42:4468-4472.
48. Clayton, Y. M. 1992. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin. Exp. Dermatol 17(Suppl. 1):37-40.
49. Clerihew, L., T. L. Lamagni, P. Brocklehurst, and W. McGuire. 2007. Candida parapsilosis infection in very low birthweight infants. Arch. Dis. Child Fetal Neonatal ed. 92:F127-F129.
50. Cocuaud, C., M. H. Rodier, G. Daniault, and C. Imbert. 2005. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J. Antimicrob. Chemother. 56:507-512.
51. Colombo, A. L., T. Guimaraes, L. R. Silva, L. P. de Almeida Monfardini, A. K. Cunha, P. Rady, T. Alves, and R. C. Rosas. 2007. Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect. Control Hosp. Epidemiol. 28:570-576.
52. Colombo, A. L., M. Nucci, B. J. Park, S. A. Nouer, B. Arthington-Skaggs, D. A. da Matta, D. Warnock, and J. Morgan. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44:2816-2823.
53. Contreras, I., J. Ponton, and G. Quindos. 1994. Prevalence of Candida parapsilosis in the oral cavities of infants in Spain. Clin. Infect. Dis. 18:480-481.
54. Costa-de-Oliveira, S., C. Pina-Vaz, D. Mendonca, and A. Goncalves Rodrigues. 2008. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 27:365-374.
55. Cowen, L. E., C. Sirjusingh, R. C. Summerbell, S. Walmsley, S. Richardson, L. M. Kohn, and J. B. Anderson. 1999. Multilocus genotypes and DNA fingerprints do not predict variation in azole resistance among clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 43:2930-2938.
56. Cuende, E., C. Barbadillo, E. M. R., C. Isasi, A. Trujillo, and J. L. Andreu. 1993. Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin. Arthritis Rheum. 22:224-241.
57. Cushing, R. D., and W. R. Fulgenzi. 1997. Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response. J. Arthroplasty 12:950.
58. Dagdeviren, M., N. Cerikcioglu, and M. Karavus. 2005. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses 48:321-326.
59. da Silva, E. H., S. Ruiz Lda, F. E. Matsumoto, M. E. Auler, M. C. Giudice, D. Moreira, W. Szeszs, and C. R. Paula. 2007. Candiduria in a public hospital of Sao Paulo (1999-2004): characteristics of the yeast isolates. Rev. Inst. Med. Trop. Sao Paulo 49:349-353.
60. Dato, V. M., and A. S. Dajani. 1990. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr. Infect. Dis. J. 9:309-314.
61. Davis, S. L., J. A. Vazquez, and P. S. McKinnon. 2007. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann. Pharmacother. 41:568-573.
62. De Bernardis, F., S. Arancia, L. Morelli, B. Hube, D. Sanglard, W. Schafer, and A. Cassone. 1999. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis. 179:201-208.
63. De Bernardis, F., R. Lorenzini, L. Morelli, and A. Cassone. 1989. Experimental rat vaginal infection with Candida parapsilosis. FEMS Microbiol. Lett. 53:137-141.
64. De Bernardis, F., R. Lorenzini, R. Verticchio, L. Agatensi, and A. Cassone. 1989. Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis. J. Clin. Microbiol. 27:2598-2603.
65. De Bernardis, F., F. Mondello, R. San Millan, J. Ponton, and A. Cassone. 1999. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J. Clin. Microbiol. 37:3481-3486.
66. De Francesco, M. A., G. Ravizzola, L. Peroni, R. Negrini, and N. Manca. 2007. Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Med. Sci. Monit. 13:BR136-BR144.
67. d'Enfert, C. 2006. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents. Curr. Drug Targets 7:465-470.
68. Denning, D. W. 2003. Echinocandin antifungal drugs. Lancet 362:1142-1151.
69. Deshpande, K. 2003. Candida parapsilosis fungaemia treated unsuccessfully with amphotericin B and fluconazole but eliminated with caspofungin: a case report. Crit. Care Resusc. 5:20-23.
70. DeVita, V. T., J. P. Utz, T. Williams, and P. P. Carbone. 1966. Candida meningitis. Arch. Intern. Med. 117:527-535.
71. Ding, C., and G. Butler. 2007. Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot. Cell 6:1310-1319.
72. Dorko, E., A. Jenca, M. Orencak, S. Viragova, and E. Pilipcinec. 2004. Otomycoses of candidal origin in eastern Slovakia. Folia Microbiol. (Praha) 49:601-604.
73. Dorko, E., E. Pilipcinec, M. Mahel, S. Viragova, I. Bracokova, F. Dorko, E. Svicky, J. Danko, E. Holoda, M. Ondrasovic, and L. Tkacikova. 2001. Yeast-like microorganisms in eye infections. Folia Microbiol. (Praha) 46:147-150.
74. Dorko, E., E. Pilipcinec, and L. Tkacikova. 2002. Candida species isolated from cerebrospinal fluid. Folia Microbiol. (Praha) 47:179-181.
75. Dostal, J., H. Dlouha, P. Malon, I. Pichova, and O. Hruskova-Heidingsfeldova. 2005. The precursor of secreted aspartic proteinase Sapp1p from Candida parapsilosis can be activated both autocatalytically and by a membrane-bound processing proteinase. Biol. Chem. 386:791-799.
76. Ellis, D. 2002. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 49(Suppl. 1):7-10.
77. Faix, R. G. 1983. Candida parapsilosis meningitis in a premature infant. Pediatr. Infect. Dis. 2:462-464.
78. Faix, R. G. 1984. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J. Pediatr. 105:616-622.
79. Falser, N. 1983. Mycotic infection of the ear: a harmless saprophyte or pathognomonic risk factor? Laryngol. Rhinol. Otol. (Stutt.) 62:140-146.
80. Farrell, J. B., D. A. Person, M. D. Lidsky, R. L. Hopfer, and D. M. Musher. 1978. Candida tropicalis arthritis - assessment of amphotericin B therapy. J. Rheumatol. 5:267-271.
81. Fekrat, S., J. A. Haller, W. R. Green, and J. D. Gottsch. 1995. Pseudophakic Candida parapsilosis endophthalmitis with a consecutive keratitis. Cornea 14:212-216.
82. Fell, J. W., and S. A. Meyer. 1967. Systematics of yeast species in the Candida parapsilosis group. Mycopathol. Mycol. Appl. 32:177-193.
83. Feman, S. S., J. C. Nichols, S. M. Chung, and T. A. Theobald. 2002. Endophthalmitis in patients with disseminated fungal disease. Trans. Am. Ophthalmol Soc. 100:67-71.
84. Fernanado, P. H., G. J. Panagoda, and L. P. Samaranayake. 1999. The relationship between the acid and alkaline phosphatase activity and the adherence of clinical isolates of Candida parapsilosis to human buccal epithelial cells. APMIS 107:1034-1042.
85. Fernandez, M., E. H. Moylett, D. E. Noyola, and C. J. Baker. 2000. Candidal meningitis in neonates: a 10-year review. Clin. Infect. Dis. 31:458-463.
86. Figueiredo, V. T., D. de Assis Santos, M. A. Resende, and J. S. Hamdan. 2007. Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections. Mycopathologia 164:27-33.
87. Filler, S. G., B. O. Ibe, P. M. Luckett, J. U. Raj, and J. E. Edwards, Jr. 1991. Candida albicans stimulates endothelial cell eicosanoid production. J. Infect. Dis. 164:928-935.
88. Fleck, R., A. Dietz, and H. Hof. 2007. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J. Antimicrob. Chemother. 59:767-771.
89. Forrest, G. N., E. Weekes, and J. K. Johnson. 2008. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J. Infect. 56:126-129.
90. Fridkin, S. K., D. Kaufman, J. R. Edwards, S. Shetty, and T. Horan. 2006. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117:1680-1687.
91. Fundyga, R. E., R. J. Kuykendall, W. Lee-Yang, and T. J. Lott. 2004. Evidence for aneuploidy and recombination in the human commensal yeast Candida parapsilosis. Infect. Genet. Evol 4:37-43.
92. Fusek, M., E. A. Smith, M. Monod, B. M. Dunn, and S. I. Foundling. 1994. Extracellular aspartic proteinases from Candida albicans, Candida tropicalis, and Candida parapsilosis yeasts differ substantially in their specificities. Biochemistry 33:9791-9799.
93. Fusek, M., E. A. Smith, M. Monod, and S. I. Foundling. 1993. Candida parapsilosis expresses and secretes two aspartic proteinases. FEBS Lett. 327:108-112.
94. Gacser, A., S. Salomon, and W. Schafer. 2005. Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker. FEMS Microbiol. Lett. 245:117-121.
95. Gacser, A., W. Schafer, J. S. Nosanchuk, S. Salomon, and J. D. Nosanchuk. 2007. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. 44:1336-1341.
96. Gacser, A., F. Stehr, C. Kroger, L. Kredics, W. Schafer, and J. D. Nosanchuk. 2007. Lipase 8 affects the pathogenesis of Candida albicans. Infect. Immun. 75:4710-4718.
97. Gacser, A., D. Trofa, W. Schafer, and J. D. Nosanchuk. 2007. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J. Clin. Investig. 117:3049-3058.
98. Garcia-Martos, P., D. Delgado, P. Marin, and J. Mira. 1993. Analysis of 40 cases of otomycosis. Enferm. Infecc. Microbiol. Clin. 11:487-489.
99. Garzoni, C., V. A. Nobre, and J. Garbino. 2007. Candida parapsilosis endocarditis: a comparative review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 26:915-926.
100. Gautret, P., M. H. Rodier, C. Kauffmann-Lacroix, and J. L. Jacquemin. 2000. Onychomycosis due to Candida parapsilosis. Mycoses 43:433-435.
101. Ghannoum, M. A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13:122-143.
102. Gilbert, C. M., and M. A. Novak. 1984. Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant. Am. J. Ophthalmol. 97:593-595.
103. Girmenia, C., P. Martino, F. De Bernardis, G. Gentile, M. Boccanera, M. Monaco, G. Antonucci, and A. Cassone. 1996. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin. Infect. Dis. 23:506-514.
104. Goldberg, P. K., P. J. Kozinn, G. J. Wise, N. Nouri, and R. B. Brooks. 1979. Incidence and significance of candiduria. JAMA 241:582-584.
105. Goldie, S. J., L. Kiernan-Tridle, C. Torres, N. Gorban-Brennan, D. Dunne, A. S. Kliger, and F. O. Finkelstein. 1996. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am. J. Kidney Dis. 28:86-91.
106. Gottlich, E., G. S. de Hoog, S. Yoshida, K. Takeo, K. Nishimura, and M. Miyaji. 1995. Cell-surface hydrophobicity and lipolysis as essential factors in human tinea nigra. Mycoses 38:489-494.
107. Greaves, I., K. Kane, N. T. Richards, T. S. Elliott, D. Adu, and J. Michael. 1992. Pigeons and peritonitis? Nephrol. Dial. Transplant. 7:967-969.
108. Gudlaugsson, O., S. Gillespie, K. Lee, J. Vande Berg, J. Hu, S. Messer, L. Herwaldt, M. Pfaller, and D. Diekema. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37:1172-1177.
109. Hanada, M., H. Imaoka, Y. Oshita, T. Rikimaru, and H. Aizawa. 2005. Successful treatment with micafungin in a case of candidemia associated with pneumonia. Kansenshogaku Zasshi 79:284-289.
110. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
111. Hay, R. J., R. Baran, M. K. Moore, and J. D. Wilkinson. 1988. Candida onychomycosis - an evaluation of the role of Candida species in nail disease. Br. J. Dermatol. 118:47-58.
112. Healy, C. M., J. R. Campbell, E. Zaccaria, and C. J. Baker. 2008. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 121:703-710.
113. Hoeprich, P. D., J. L. Ingraham, E. Kleker, and M. J. Winship. 1974. Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J. Infect. Dis. 130:112-118.
114. Horn, D., D. Neofytos, J. Fishman, W. Steinbach, E. Anaisie, K. A. Marr, M. Pfaller, and A. Olyaei. 2007. Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia. Eur. J. Clin. Microbiol. Infect. Dis. 26:907-914.
115. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.
116. Hsieh, W. B., and C. Leung. 2005. Candidal arthritis after complete treatment of systemic candidiasis. J. Chin Med. Assoc. 68:191-194.
117. Huang, Y. C., T. Y. Lin, H. S. Leu, H. L. Peng, J. H. Wu, and H. Y. Chang. 1999. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection 27:97-102.
118. Huang, Y. C., T. Y. Lin, R. I. Lien, Y. H. Chou, C. Y. Kuo, P. H. Yang, and W. S. Hsieh. 2000. Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection. J. Infect. 40:171-175.
119. Hube, B., and J. Naglik. 2001. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147:1997-2005.
120. Hube, B., F. Stehr, M. Bossenz, A. Mazur, M. Kretschmar, and W. Schafer. 2000. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch. Microbiol. 174:362-374.
121. Hung, C. C., Y. C. Chen, S. C. Chang, K. T. Luh, and W. C. Hsieh. 1996. Nosocomial candidemia in a university hospital in Taiwan. J. Formos. Med. Assoc. 95:19-28.
122. Jaeger, K. E., F. J. Adrian, H. E. Meyer, R. E. Hancock, and U. K. Winkler. 1992. Extracellular lipase from Pseudomonas aeruginosa is an amphiphilic protein. Bioch. Biophys. Acta 1120:315-321.
123. Jayatilake, J. A., Y. H. Samaranayake, and L. P. Samaranayake. 2005. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J. Oral Pathol. Med. 34:240-246.
124. Jimenez-Mejias, M. E., I. Moreno-Maqueda, C. Regordan, and J. L. Artola-Igarza. 1993. External cerebrospinal fluid diversion and Candida parapsilosis meningitis. Treatment with fluconazole. Med. Clin. (Barcelona) 100:156.
125. Joachim, H., and S. Polayes. 1940. Subacute endocarditis and systemic mycosis (monilia). JAMA 205-208.
126. Kaitwatcharachai, C. 2002. Candida parapsilosis peritonitis in patients on CAPD. Mycopathologia 154:181-184.
127. Kaloterakis, A., I. Rizos, G. Goumas, A. Filiotou, J. Barbetseas, S. Papathanasiou, and P. Toutouzas. 2003. Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature. J. Heart Valve Dis. 12:652-658.
128. Kantarcioglu, A. S., and A. Yucel. 2002. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 45:160-165.
129. Kartsonis, N., J. Killar, L. Mixson, C. M. Hoe, C. Sable, K. Bartizal, and M. Motyl. 2005. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Antimicrob. Agents Chemother. 49:3616-3623.
130. Kato, M., M. Ozeki, A. Kikuchi, and T. Kanbe. 2001. Phylogenetic relationship and mode of evolution of yeast DNA topoisomerase II gene in the pathogenic Candida species. Gene 272:275-281.
131. Katragkou, A., A. Chatzimoschou, M. Simitsopoulou, M. Dalakiouridou, E. Diza-Mataftsi, C. Tsantali, and E. Roilides. 2007. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob. Agents Chemother. 52:357-360.
132. Kauffman, C. A., S. F. Bradley, and A. K. Vine. 1993. Candida endophthalmitis associated with intraocular lens implantation: efficacy of fluconazole therapy. Mycoses 36:13-17.
133. Kaufman, D., R. Boyle, K. C. Hazen, J. T. Patrie, M. Robinson, and L. G. Donowitz. 2001. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345:1660-1666.
134. Kaufman, D. A. 2008. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? Curr. Opin. Pediatr. 20:332-340.
135. Kicklighter, S. D., S. C. Springer, T. Cox, T. C. Hulsey, and R. B. Turner. 2001. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 107:293-298.
136. Kim, S. K., K. El Bissati, and C. Ben Mamoun. 2006. Amino acids mediate colony and cell differentiation in the fungal pathogen Candida parapsilosis. Microbiology 152:2885-2894.
137. King, R. D., J. C. Lee, and A. L. Morris. 1980. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect. Immun. 27:667-674.
138. Kobayashi, C. C., O. F. de Fernandes, K. C. Miranda, E. D. de Sousa, and R. Silva Mdo. 2004. Candiduria in hospital patients: a study prospective. Mycopathologia 158:49-52.
139. Kocsube, S., M. Toth, C. Vagvolgyi, I. Doczi, M. Pesti, I. Pocsi, J. Szabo, and J. Varga. 2007. Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary. J. Med. Microbiol. 56:190-195.
140. Kojic, E. M., and R. O. Darouiche. 2003. Comparison of adherence of Candida albicans and Candida parapsilosis to silicone catheters in vitro and in vivo. Clin. Microbiol. Infect. 9:684-690.
141. Koklu, E., T. Gunes, S. Kurtoglu, S. Gokoglu, and S. Koklu. 2007. Onychomycosis in a premature infant caused by Candida parapsilosis. Pediatr. Dermatol. 24:155-156.
142. Kossoff, E. H., E. S. Buescher, and M. G. Karlowicz. 1998. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr. Infect. Dis. J. 17:504-508.
143. Kovac, L., J. Lazowska, and P. P. Slonimski. 1984. A yeast with linear molecules of mitochondrial DNA. Mol. Gen. Genet. 197:420-424.
144. Krcmery, V., M. Fric, M. Pisarcikova, M. Huttova, J. Filka, K. Kralinsky, H. Hupkova, J. Hanzen, J. Trupl, and M. Liskova. 2000. Fungemia in neonates: report of 80 cases from seven university hospitals. Pediatrics 105:913-914.
145. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
146. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
147. Kuhn, D. M., P. K. Mikherjee, T. A. Clark, C. Pujol, J. Chandra, R. A. Hajjeh, D. W. Warnock, D. R. Soil, and M. A. Ghannoum. 2004. Candida parapsilosis characterization in an outbreak setting. Emerg. Infect. Dis. 10:1074-1081.
148. Kurtzman, C. P., and C. J. Robnett. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35:1216-1223.
149. Kwon-Chung, K. J., D. Lehman, C. Good, and P. T. Magee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49:571-575.
150. Laffey, S. F., and G. Butler. 2005. Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology 151:1073-1081.
151. Laverdiere, M., D. Hoban, C. Restieri, and F. Habel. 2002. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. J. Antimicrob. Chemother. 50:119-123.
152. Lee, J. S., J. H. Shin, K. Lee, M. N. Kim, B. M. Shin, Y. Uh, W. G. Lee, H. S. Lee, C. L. Chang, S. H. Kim, M. G. Shin, S. P. Suh, and D. W. Ryang. 2007. Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea. Yonsei Med. J. 48:779-786.
153. Legout, L., M. Assal, P. Rohner, D. Lew, L. Bernard, and P. Hoffmeyer. 2006. Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient. Scand. J. Infect. Dis. 38:728-730.
154. Lejko-Zupanc, T., and M. Kozelj. 1997. A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. J. Infect. 35:81-82.
155. Levin, A. S., S. F. Costa, N. S. Mussi, M. Basso, S. I. Sinto, C. Machado, D. C. Geiger, M. C. Villares, A. Z. Schreiber, A. A. Barone, and M. L. Branchini. 1998. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn. Microbiol. Infect. Dis. 30:243-249.
156. Levy, I., L. G. Rubin, S. Vasishtha, V. Tucci, and S. K. Sood. 1998. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin. Infect. Dis. 26:1086-1088.
157. Lin, D., L. C. Wu, M. G. Rinaldi, and P. F. Lehmann. 1995. Three distinct genotypes within Candida parapsilosis from clinical sources. J. Clin. Microbiol. 33:1815-1821.
158. Linder, N., G. Klinger, I. Shalit, I. Levy, S. Ashkenazi, G. Haski, O. Levit, and L. Sirota. 2003. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J. Antimicrob. Chemother. 52:663-667.
159. Lipton, S. A., W. F. Hickey, J. H. Morris, and J. Loscalzo. 1984. Candidal infection in the central nervous system. Am. J. Med. 76:101-108.
160. Logue, M. E., S. Wong, K. H. Wolfe, and G. Butler. 2005. A genome sequence survey shows that the pathogenic yeast Candida parapsilosis has a defective MTLa1 allele at its mating type locus. Eukaryot. Cell 4:1009-1017.
161. Longshaw, C. M., A. M. Farrell, J. D. Wright, and K. T. Holland. 2000. Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases. Microbiology 146:1419-1427.
162. Lopez-Ciudad, V., M. J. Castro-Orjales, C. Leon, C. Sanz-Rodriguez, M. J. de la Torre-Fernandez, M. A. Perez de Juan-Romero, M. D. Collell-Llach, and M. D. Diaz-Lopez. 2006. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infect. Dis. 6:73.
163. Lott, T. J., R. J. Kuykendall, S. F. Welbel, A. Pramanik, and B. A. Lasker. 1993. Genomic heterogeneity in the yeast Candida parapsilosis. Curr. Genet. 23:463-467.
164. Lupetti, A., A. Tavanti, P. Davini, E. Ghelardi, V. Corsini, I. Merusi, A. Boldrini, M. Campa, and S. Senesi. 2002. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J. Clin. Microbiol. 40:2363-2369.
165. MacDonald, L., C. Baker, and C. Chenoweth. 1998. Risk factors for candidemia in a children's hospital. Clin. Infect. Dis. 26:642-645.
166. Mallie, M., J. M. Bastide, A. Blancard, A. Bonnin, S. Bretagne, M. Cambon, J. Chandenier, V. Chauveau, B. Couprie, A. Datry, M. Feuilhade, R. Grillot, C. Guiguen, V. Lavarde, V. Letscher, M. D. Linas, A. Michel, O. Morin, A. Paugam, M. A. Piens, H. Raberin, E. Tissot, D. Toubas, and A. Wade. 2005. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Int. J. Antimicrob. Agents 25:321-328.
167. Manzano-Gayosso, P., F. Hernandez-Hernandez, L. J. Mendez-Tovar, J. Gonzalez-Monroy, and R. Lopez-Martinez. 2003. Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD). Mycoses 46:425-429.
168. Marco, F., C. Danes, M. Almela, A. Jurado, J. Mensa, J. P. de la Bellacasa, M. Espasa, J. A. Martinez, and M. T. Jimenez de Anta. 2003. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagn. Microbiol. Infect. Dis. 46:259-264.
169. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-1554.
170. Martin, T. J., J. E. Kerschner, and V. A. Flanary. 2005. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int. J. Pediatr. Otorhinolaryngol. 69:1503-1508.
171. Martino, P., C. Girmenia, A. Micozzi, R. Raccah, G. Gentile, M. Venditti, and F. Mandelli. 1993. Fungemia in patients with leukemia. Am. J. Med. Sci. 306:225-232.
172. McCray, E., N. Rampell, S. L. Solomon, W. W. Bond, W. J. Martone, and D. O'Day. 1986. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J. Clin. Microbiol. 24:625-628.
173. McGinley, K. J., E. L. Larson, and J. J. Leyden. 1988. Composition and density of microflora in the subungual space of the hand. J. Clin. Microbiol. 26:950-953.
174. Medrano, D. J., R. S. Brilhante, A. Cordeiro Rde, M. F. Rocha, S. H. Rabenhorst, and J. J. Sidrim. 2006. Candidemia in a Brazilian hospital: the importance of Candida parapsilosis. Rev. Inst. Med. Trop. Sao Paulo 48:17-20.
175. Merkerova, M., J. Dostal, M. Hradilek, I. Pichova, and O. Hruskova-Heidingsfeldova. 2006. Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis. FEMS Yeast Res. 6:1018-1026.
176. Mermel, L. A., B. M. Farr, R. J. Sherertz, I. I. Raad, N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:1249-1272.
177. Messer, S. A., R. N. Jones, and T. R. Fritsche. 2006. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J. Clin. Microbiol. 44:1782-1787.
178. Miskin, J. E., A. M. Farrell, W. J. Cunliffe, and K. T. Holland. 1997. Propionibacterium acnes, a resident of lipid-rich human skin, produces a 33 kDa extracellular lipase encoded by gehA. Microbiology 143:1745-1755.
179. Monod, M., and M. Borg-von-Zepelin. 2002. Secreted aspartic proteases as virulence factors of Candida species. Biol. Chem. 383:1087-1093.
180. Mora-Duarte, J., R. Betts, C. Rotstein, A. L. Colombo, L. Thompson-Moya, J. Smietana, R. Lupinacci, C. Sable, N. Kartsonis, and J. Perfect. 2002. Comparison of caspofungin and amphotericin B for invasive candidiasis. N. Engl. J. Med. 347:2020-2029.
181. Moudgal, V., T. Little, D. Boikov, and J. A. Vazquez. 2005. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob. Agents Chemother. 49:767-769.
182. Mugge, C., U. F. Haustein, and P. Nenoff. 2006. Causative agents of onychomycosis - a retrospective study. J. Dtsch. Dermatol. Ges. 4:218-228.
183. Mujica, M. T., J. L. Finquelievich, V. Jewtuchowicz, and C. A. Iovannitti. 2004. Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001. Rev. Argent Microbiol. 36:107-112.
184. Mukherjee, P. K., D. J. Sheehan, C. A. Hitchcock, and M. A. Ghannoum. 2005. Combination treatment of invasive fungal infections. Clin. Microbiol. Rev. 18:163-194.
185. Naglik, J. R., G. Newport, T. C. White, L. L. Fernandes-Naglik, J. S. Greenspan, D. Greenspan, S. P. Sweet, S. J. Challacombe, and N. Agabian. 1999. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun. 67:2482-2490.
186. Nakamura, T., and H. Takahashi. 2006. Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia. J. Infect. Chemother. 12:132-138.
187. Namkinga, L. A., M. I. Matee, A. K. Kivaisi, A. Kullaya, and E. E. Mneney. 2005. Identification of Candida strains isolated from Tanzanian pregnant women with vaginal candidiasis. East Afr. Med. J. 82:226-234.
188. Neugnot, V., G. Moulin, E. Dubreucq, and F. Bigey. 2002. The lipase/acyltransferase from Candida parapsilosis: molecular cloning and characterization of purified recombinant enzymes. Eur. J. Biochem. 269:1734-1745.
189. Ng, K. P., T. L. Saw, S. L. Na, and T. S. Soo-Hoo. 2001. Systemic Candida infection in University hospital 1997-1999: the distribution of Candida biotypes and antifungal susceptibility patterns. Mycopathologia 149:141-146.
190. Nguyen, M. H., J. E. Peacock, Jr., D. C. Tanner, A. J. Morris, M. L. Nguyen, D. R. Snydman, M. M. Wagener, and V. L. Yu. 1995. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch. Intern. Med. 155:2429-2435.
191. Nosek, J., L. Adamikova, J. Zemanova, L. Tomaska, R. Zufferey, and C. B. Mamoun. 2002. Genetic manipulation of the pathogenic yeast Candida parapsilosis. Curr. Genet. 42:27-35.
192. Nosek, J., N. Dinouel, L. Kovac, and H. Fukuhara. 1995. Linear mitochondrial DNAs from yeasts: telomeres with large tandem repetitions. Mol. Gen. Genet. 247:61-72.
193. Nosek, J., M. Novotna, Z. Hlavatovicova, D. W. Ussery, J. Fajkus, and L. Tomaska. 2004. Complete DNA sequence of the linear mitochondrial genome of the pathogenic yeast Candida parapsilosis. Mol. Genet. Genomics 272:173-180.
194. Nosek, J., L. Tomaska, A. Rycovska, and H. Fukuhara. 2002. Mitochondrial telomeres as molecular markers for identification of the opportunistic yeast pathogen Candida parapsilosis. J. Clin. Microbiol. 40:1283-1289.
195. Nyirjesy, P., A. B. Alexander, and M. V. Weitz. 2005. Vaginal Candida parapsilosis: pathogen or bystander? Infect. Dis. Obstet. Gynecol. 13:37-41.
196. Nyirjesy, P., S. M. Seeney, M. H. Grody, C. A. Jordan, and H. R. Buckley. 1995. Chronic fungal vaginitis: the value of cultures. Am. J. Obstet. Gynecol. 173:820-823.
197. O'Day, D. M. 1985. Value of a centralized surveillance system during a national epidemic of endophthalmitis. Ophthalmology 92:309-315.
198. Odds, F. C. 1987. Candida infections: an overview. Crit. Rev. Microbiol. 15:1-5.
199. Odds, F. C., M. Motyl, R. Andrade, J. Bille, E. Canton, M. Cuenca-Estrella, A. Davidson, C. Durussel, D. Ellis, E. Foraker, A. W. Fothergill, M. A. Ghannoum, R. A. Giacobbe, M. Gobernado, R. Handke, M. Laverdiere, W. Lee-Yang, W. G. Merz, L. Ostrosky-Zeichner, J. Peman, S. Perea, J. R. Perfect, M. A. Pfaller, L. Proia, J. H. Rex, M. G. Rinaldi, J. L. Rodriguez-Tudela, W. A. Schell, C. Shields, D. A. Sutton, P. E. Verweij, and D. W. Warnock. 2004. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 42:3475-3482.
200. Odio, C. M., R. Araya, L. E. Pinto, C. E. Castro, S. Vasquez, B. Alfaro, A. Saenz, M. L. Herrera, and T. J. Walsh. 2004. Caspofungin therapy of neonates with invasive candidiasis. Pediatr. Infect. Dis. J. 23:1093-1097.
201. Oppenheim, B. A., R. Herbrecht, and S. Kusne. 1995. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin. Infect. Dis. 21:1145-1153.
202. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Horowitz, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother. 47:3149-3154.
203. Otaki, M., M. Kawashima, A. Yamaguchi, and N. Kitamura. 1992. A case report of Candida prosthetic endocarditis: an autopsy review. Kyobu Geka 45:335-338.
204. Otero, L., V. Palacio, F. Carreno, F. J. Mendez, and F. Vazquez. 1998. Vulvovaginal candidiasis in female sex workers. Int. J. STD AIDS 9:526-530.
205. Pagano, L., A. Antinori, A. Ammassari, L. Mele, A. Nosari, L. Melillo, B. Martino, M. Sanguinetti, F. Equitani, F. Nobile, M. Carotenuto, E. Morra, G. Morace, and G. Leone. 1999. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur. J. Haematol. 63:77-85.
206. Panagoda, G. J., A. N. Ellepola, and L. P. Samaranayake. 2001. Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity. Mycoses 44:29-35.
207. Patel, R., K. L. Grogg, W. D. Edwards, A. J. Wright, and N. M. Schwenk. 2000. Death from inappropriate therapy for Lyme disease. Clin. Infect. Dis. 31:1107-1109.
208. Pfaller, M. A., L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2008. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J. Clin. Microbiol. 46:150-156.
209. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2005. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J. Clin. Microbiol. 43:5425-5427.
210. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
211. Pfaller, M. A., and D. J. Diekema. 2004. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin. Microbiol. Infect. 10(Suppl. 1):11-23.
212. Pfaller, M. A., D. J. Diekema, D. L. Gibbs, V. A. Newell, J. F. Meis, I. M. Gould, W. Fu, A. L. Colombo, and E. Rodriguez-Noriega. 2007. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol. 45:1735-1745.
213. Pfaller, M. A., D. J. Diekema, R. N. Jones, H. S. Sader, A. C. Fluit, R. J. Hollis, and S. A. Messer. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39:3254-3259.
214. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis. 2003. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol. 41:1440-1446.
215. Pfaller, M. A., R. N. Jones, G. V. Doern, H. S. Sader, R. J. Hollis, S. A. Messer, et al. 1998. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. J. Clin. Microbiol. 36:1886-1889.
216. Pfaller, M. A., S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2003. Caspofungin activity against clinical isolates of fluconazole-resistant Candida. J. Clin. Microbiol. 41:5729-5731.
217. Pfaller, M. A., S. A. Messer, and R. J. Hollis. 1995. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn. Microbiol. Infect. Dis. 21:9-14.
218. Pfaller, M. A., S. A. Messer, R. J. Hollis, R. N. Jones, G. V. Doern, M. E. Brandt, and R. A. Hajjeh. 1998. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole. Antimicrob. Agents Chemother. 42:3242-3244.
219. Pichova, I., L. Pavlickova, J. Dostal, E. Dolejsi, O. Hruskova-Heidingsfeldova, J. Weber, T. Ruml, and M. Soucek. 2001. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur. J. Biochem. 268:2669-2677.
220. Pierrotti, L. C., and L. M. Baddour. 2002. Fungal endocarditis, 1995-2000. Chest 122:302-310.
221. Plouffe, J. F., D. G. Brown, J. Silva, Jr., T. Eck, R. L. Stricof, and F. R. Fekety, Jr. 1977. Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch. Intern. Med. 137:1686-1689.
222. Pugh, D., and R. A. Cawson. 1977. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 15:29-35.
223. Quindos, G., M. T. Ruesga, E. Martin-Mazuelos, R. Salesa, R. Alonso-Vargas, A. J. Carrillo-Munoz, S. Brena, R. San Millan, and J. Ponton. 2004. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev. Iberoam. Micol. 21:63-69.
224. Ramage, G., J. P. Martinez, and J. L. Lopez-Ribot. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6:979-986.
225. Ramage, G., S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.
226. Ran, Y., T. Yoshiike, and H. Ogawa. 1993. Lipase of Malassezia furfur: some properties and their relationship to cell growth. J. Med. Vet. Mycol. 31:77-85.
227. Reuss, O., A. Vik, R. Kolter, and J. Morschhauser. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127.
228. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
229. Rhem, M. N., K. R. Wilhelmus, and R. L. Font. 1996. Infectious crystalline keratopathy caused by Candida parapsilosis. Cornea 15:543-545.
230. Richter, S. S., R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 43:2155-2162.
231. Rodero, L., G. Davel, M. Soria, W. Vivot, S. Cordoba, C. E. Canteros, and A. Saporiti. 2005. Multicenter study of fungemia due to yeasts in Argentina. Rev. Argent. Microbiol. 37:189-195.
232. Roilides, E., E. Farmaki, J. Evdoridou, J. Dotis, E. Hatziioannidis, M. Tsivitanidou, E. Bibashi, I. Filioti, D. Sofianou, C. Gil-Lamaignere, F. M. Mueller, and G. Kremenopoulos. 2004. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur. J. Clin. Microbiol. Infect. Dis. 23:745-750.
233. Rosa, R. H., Jr., D. Miller, and E. C. Alfonso. 1994. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 101:1005-1013.
234. Rosen, R., and A. H. Friedman. 1973. Successfully treated postoperative Candida parakrusei endophthalmitis. Am. J. Ophthalmol. 76:574-577.
235. Roy, B., and S. A. Meyer. 1998. Confirmation of the distinct genotype groups within the form species Candida parapsilosis. J. Clin. Microbiol. 36:216-218.
236. Ruchel, R., B. Boning, and M. Borg. 1986. Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro. Infect. Immun. 53:411-419.
237. Ruchel, R., F. de Bernardis, T. L. Ray, P. A. Sullivan, and G. T. Cole. 1992. Candida acid proteinases. J. Med. Vet. Mycol. 30(Suppl. 1):123-132.
238. Ruzicka, F., V. Hola, M. Votava, and R. Tejkalova. 2007. Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method. Folia Microbiol. (Praha) 52:209-214.
239. Rycovska, A., M. Valach, L. Tomaska, M. Bolotin-Fukuhara, and J. Nosek. 2004. Linear versus circular mitochondrial genomes: intraspecies variability of mitochondrial genome architecture in Candida parapsilosis. Microbiology 150:1571-1580.
240. Saiman, L., E. Ludington, J. D. Dawson, J. E. Patterson, S. Rangel-Frausto, R. T. Wiblin, H. M. Blumberg, M. Pfaller, M. Rinaldi, J. E. Edwards, R. P. Wenzel, and W. Jarvis. 2001. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr. Infect. Dis. J. 20:1119-1124.
241. Saito, Y., M. Takahashi, A. Sato, T. Katsuki, U. Ikeda, and K. Shimada. 2001. Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation. Intern. Med. 40:403-404.
242. Samaranayake, L. P., L. McLaughlin, and T. MacFarlane. 1988. Adherence of Candida species to fibrin clots in vitro. Mycopathologia 102:135-138.
243. Sanchez, V., J. A. Vazquez, D. Barth-Jones, L. Dembry, J. D. Sobel, and M. J. Zervos. 1993. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am. J. Med. 94:577-582.
244. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
245. San Miguel, L. G., J. Cobo, E. Otheo, A. Sanchez-Sousa, V. Abraira, and S. Moreno. 2005. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect. Control Hosp. Epidemiol. 26:548-552.
246. Sarvikivi, E., O. Lyytikainen, D. R. Soll, C. Pujol, M. A. Pfaller, M. Richardson, P. Koukila-Kahkola, P. Luukkainen, and H. Saxen. 2005. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J. Clin. Microbiol. 43:2729-2735.
247. Saxen, H., M. Virtanen, P. Carlson, K. Hoppu, M. Pohjavuori, M. Vaara, J. Vuopio-Varkila, and H. Peltola. 1995. Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr. Infect. Dis. J. 14:776-781.
248. Schaller, M., C. Borelli, H. C. Korting, and B. Hube. 2005. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48:365-377.
249. Schaller, M., N. Krnjaic, M. Niewerth, G. Hamm, B. Hube, and H. C. Korting. 2003. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans. J. Med. Microbiol. 52:247-249.
250. Schrader, N., and G. Isaacson. 2003. Fungal otitis externa - its association with fluoroquinolone eardrops. Pediatrics 111:1123.
251. Segal, R., A. Kimchi, A. Kritzman, R. Inbar, and Z. Segal. 2000. The frequency of Candida parapsilosis in onychomycosis. An epidemiological survey in Israel. Mycoses 43:349-353.
252. sel-Mohandes, A. E., L. Johnson-Robbins, J. F. Keiser, S. J. Simmens, and M. V. Aure. 1994. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatric Infect. Dis. J. 13:520-524.
253. Shimizu, M. T., N. Q. Almeida, V. Fantinato, and C. S. Unterkircher. 1996. Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses 39:161-167.
254. Shin, J. H., S. J. Kee, M. G. Shin, S. H. Kim, D. H. Shin, S. K. Lee, S. P. Suh, and D. W. Ryang. 2002. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 40:1244-1248.
255. Smego, R. A., Jr., J. R. Perfect, and D. T. Durack. 1984. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev. Infect. Dis. 6:791-801.
256. Sobel, J. D. 2007. Vulvovaginal candidosis. Lancet 369:1961-1971.
257. Sobel, J. D., and J. A. Vazquez. 1996. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin. Infect. Dis. 22:726-727.
258. Sofair, A. N., G. M. Lyon, S. Huie-White, E. Reiss, L. H. Harrison, L. T. Sanza, B. A. Arthington-Skaggs, and S. K. Fridkin. 2006. Epidemiology of community-onset candidemia in Connecticut and Maryland. Clin. Infect. Dis. 43:32-39.
259. Solomon, R., S. A. Biser, E. D. Donnenfeld, H. D. Perry, S. J. Doshi, and C. C. Lee. 2004. Candida parapsilosis keratitis following treatment of epithelial ingrowth after laser in situ keratomileusis. Eye Contact Lens 30:85-86.
260. Solomon, S. L., H. Alexander, J. W. Eley, R. L. Anderson, H. C. Goodpasture, S. Smart, R. M. Furman, and W. J. Martone. 1986. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr. Infect. Dis. 5:680-685.
261. Solomon, S. L., R. F. Khabbaz, R. H. Parker, R. L. Anderson, M. A. Geraghty, R. M. Furman, and W. J. Martone. 1984. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J. Infect. Dis. 149:98-102.
262. Spellberg, B. J., S. G. Filler, and J. E. Edwards, Jr. 2006. Current treatment strategies for disseminated candidiasis. Clin. Infect. Dis. 42:244-251.
263. Staib, P., M. Kretschmar, T. Nichterlein, H. Hof, and J. Morschhauser. 2002. Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect. Immun. 70:921-927.
264. Stehr, F., A. Felk, A. Gacser, M. Kretschmar, B. Mahnss, K. Neuber, B. Hube, and W. Schafer. 2004. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res. 4:401-408.
265. Stern, W. H., E. Tamura, R. A. Jacobs, V. G. Pons, R. D. Stone, D. M. O'Day, and A. R. Irvine. 1985. Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases. Ophthalmology 92:1701-1709.
266. Stransky, T. J. 1981. Postoperative endophthalmitis secondary to Candida parapsilosis. A case treated by vitrectomy and intravitreous therapy. Retina 1:179-185.
267. Tavanti, A., A. D. Davidson, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
268. Tavanti, A., N. A. Gow, S. Senesi, M. C. Maiden, and F. C. Odds. 2003. Optimization and validation of multilocus sequence typing for Candida albicans. J. Clin. Microbiol. 41:3765-3776.
269. Taylor, B. N., P. Staib, A. Binder, A. Biesemeier, M. Sehnal, M. Rollinghoff, J. Morschhauser, and K. Schroppel. 2005. Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection. Infect. Immun. 73:1828-1835.
270. Torres, H. A., D. P. Kontoyiannis, and K. V. Rolston. 2004. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer 12:511-516.
271. Tortorano, A. M., A. L. Rigoni, E. Biraghi, A. Prigitano, and M. A. Viviani. 2003. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J. Antimicrob. Chemother. 52:679-682.
272. Tseng, S. H., and K. C. Ling. 1995. Late microbial keratitis after corneal transplantation. Cornea 14:591-594.
273. Tumbarello, M., B. Posteraro, E. M. Trecarichi, B. Fiori, M. Rossi, R. Porta, K. de Gaetano Donati, M. La Sorda, T. Spanu, G. Fadda, R. Cauda, and M. Sanguinetti. 2007. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45:1843-1850.
274. Tunkel, A. R., C. Y. Thomas, and B. Wispelwey. 1993. Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am. J. Med. 94:100-103.
275. Tyski, S., S. Tylewska, W. Hryniewicz, and J. Jeljaszewicz. 1987. Induction of human neutrophils chemotaxis by staphylococcal lipase. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 265:360-368.
276. Uko, S., L. M. Soghier, M. Vega, J. Marsh, G. T. Reinersman, L. Herring, V. A. Dave, S. Nafday, and L. P. Brion. 2006. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 117:1243-1252.
277. van Asbeck, E. C., Y. C. Huang, A. N. Markham, K. V. Clemons, and D. A. Stevens. 2007. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 164:287-293.
278. Vasquez, J. C., M. Hart, C. F. Denney, R. Pedowitz, and E. J. Ziegler. 2002. Fungal arthritis of the knee caused by Candida parapsilosis in a kidney transplant recipient. J. Clin. Rheumatol. 8:147-150.
279. Vennewald, I., J. Schonlebe, and E. Klemm. 2003. Mycological and histological investigations in humans with middle ear infections. Mycoses 46:12-18.
280. Voice, R. A., S. F. Bradley, J. A. Sangeorzan, and C. A. Kauffman. 1994. Chronic candidal meningitis: an uncommon manifestation of candidiasis. Clin. Infect. Dis. 19:60-66.
281. Voss, A., R. J. Hollis, M. A. Pfaller, R. P. Wenzel, and B. N. Doebbeling. 1994. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J. Clin. Microbiol. 32:975-980.
282. Wada, M., H. Baba, and S. Imura. 1998. Prosthetic knee Candida parapsilosis infection. J. Arthroplasty 13:479-482.
283. Waggoner-Fountain, L. A., M. W. Walker, R. J. Hollis, M. A. Pfaller, J. E. Ferguson II, R. P. Wenzel, and L. G. Donowitz. 1996. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin. Infect. Dis. 22:803-808.
284. Walsh, T. J. 2002. Echinocandins - an advance in the primary treatment of invasive candidiasis. N. Engl. J. Med. 347:2070-2072.
285. Wang, A. Y., A. W. Yu, P. K. Li, P. K. Lam, C. B. Leung, K. N. Lai, and S. F. Lui. 2000. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am. J. Kidney Dis. 36:1183-1192.
286. Weems, J. J., Jr. 1992. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin. Infect. Dis. 14:756-766.
287. Weems, J. J., Jr., M. E. Chamberland, J. Ward, M. Willy, A. A. Padhye, and S. L. Solomon. 1987. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J. Clin. Microbiol. 25:1029-1032.
288. Weinberger, M., S. Sweet, L. Leibovici, S. D. Pitlik, and Z. Samra. 2003. Correlation between candiduria and departmental antibiotic use. J. Hosp. Infect. 53:183-186.
289. Weintrub, P. S., A. Chapman, and R. Piecuch. 1994. Renal fungus ball in a premature infant successfully treated with fluconazole. Pediatr. Infect. Dis. J. 13:1152-1154.
290. Welbel, S. F., M. M. McNeil, R. J. Kuykendall, T. J. Lott, A. Pramanik, R. Silberman, A. D. Oberle, L. A. Bland, S. Aguero, M. Arduino, S. Crow, and W. R. Jarvis. 1996. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak. Pediatric Infect. Dis. J. 15:998-1002.
291. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.
292. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
293. Wong, P. N., S. K. Mak, K. Y. Lo, G. M. Tong, and A. K. Wong. 2000. A retrospective study of seven cases of Candida parapsilosis peritonitis in CAPD patients: the therapeutic implications. Perit. Dial. Int. 20:76-79.
294. Wong, V. K., W. Tasman, R. C. Eagle, Jr., and A. Rodriguez. 1997. Bilateral Candida parapsilosis endophthalmitis. Arch. Ophthalmol 115:670-672.
295. Xess, I., N. Jain, F. Hasan, P. Mandal, and U. Banerjee. 2007. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 35:256-259.
296. Yalaz, M., M. Akisu, S. Hilmioglu, S. Calkavur, B. Cakmak, and N. Kultursay. 2006. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate. Mycoses 49:242-245.
297. Yamamoto, T., K. Nohara, K. Uchida, and H. Yamaguchi. 1992. Purification and characterization of secretory proteinase of Candida albicans. Microbiol. Immunol. 36:637-641.
298. Yang, S. H., J. L. Pao, and Y. S. Hang. 2001. Staged reimplantation of total knee arthroplasty after Candida infection. J. Arthroplasty 16:529-532.
299. Yinnon, A. M., D. Gabay, D. Raveh, Y. Schlesinger, I. Slotki, D. Attias, and B. Rudensky. 1999. Comparison of peritoneal fluid culture results from adults and children undergoing CAPD. Perit. Dial. Int. 19:51-55.
300. Zahid, M. A., S. A. Klotz, and D. R. Hinthorn. 1994. Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. Chest 105:1597-1598.
301. Zaias, N. 1972. Onychomycosis. Arch. Dermatol. 105:263-274.